-
Minister urges regional gov't to crack down pharmaceutical frauds
17 Dec 2025 13:25 GMT
… down on fraudulent practices in pharmaceutical procurement across local hospitals if … now I audit all the expenditures. Mr. (Bengkulu Governor), if you …
-
Bajaj Auto and ITC emerge top net forex earners outside IT, Pharma
15 Dec 2025 22:44 GMT
… -oriented companies across IT, pharma and automobiles are likely to … margins. While IT and pharma are traditionally known for … outside the IT and pharma sectors include FMCG major … of agri-commodities. Its forex expenditure — primarily towards raw material …
-
CRISPR Market Growth at 16.8% CAGR, Expected to Reach US$15.25B by 2033, North America Holds 42%
17 Dec 2025 12:30 GMT
… and research institutes, pharmaceutical and biotechnology companies, and … across research laboratories, pharmaceutical companies, and academic … timelines and costs. Pharmaceutical and biotechnology companies … high R&D expenditure in genetic engineering, …
-
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
17 Dec 2025 13:30 GMT
… a favorable safety profile, and pharmacokinetics profile suitable for once-daily … evaluate the safety, tolerability, pharmacokinetics and pharmacodynamic activity of ACCG-2671 … satiety, leptin sensitivity and energy expenditure. Preclinical data from current …
-
Intranasal Drug Delivery Market is expected to reach US$ 20.7 billion by 2031 | DataM Intelligence
17 Dec 2025 11:54 GMT
… healthcare expenditure, and strong government investment in pharmaceutical … products. Retail pharmacies and online platforms … fastest growth. Expanding pharmaceutical manufacturing, growing …
Pfizer Inc
Valeant Pharmaceuticals International, Inc
Merck …
-
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
17 Dec 2025 11:30 GMT
-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an acceptable approvable primary endpoint with key secondary …
-
Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy
17 Dec 2025 14:15 GMT
The patent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to female patients with sexual dysfunction in order to increase sexual quality of life
Female sexual dysfunction is an …
-
Age-Related Macular Degeneration Market to Reach US$26.58 Billion by 2033, Driven by Advancements in Anti-VEGF Therapies
17 Dec 2025 09:29 GMT
… . The presence of leading pharmaceutical companies and favorable reimbursement frameworks … rapid population aging, increasing healthcare expenditure, and improving access to … Hoffmann La Roche Ltd
• Regeneron Pharmaceuticals Inc
• Novartis AG
• Bayer …
-
Pharmaceutical Filtration Market worth $21.75 billion by 2030 | MarketsandMarkets™
12 Dec 2025 16:56 GMT
… are reshaping the pharmaceutical filtration landscape. Regulatory … such as active pharmaceutical ingredient (API) … diseases. Growing healthcare expenditure, large patient populations, … GMP compliance, upgrading pharmaceutical infrastructure, and promoting …
-
MedCity Pivot Podcast: A Flexible Approach to Pharmacy Benefits Management
12 Dec 2025 02:53 GMT
… a flexible approach to pharmacy benefit management. In this … or modular approach to pharmacy benefits management?
Matt Gibbs … many cases pass medical expenditures when pharmacy was 10 to 15% … new flexible approach to pharmacy benefits. Management. Thank you …